Literature DB >> 4957989

Waldenström's macroglobulinemia. A study of ten cases.

R J Cohen, R A Bohannon, R O Wallerstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4957989     DOI: 10.1016/0002-9343(66)90022-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome.

Authors:  K Harkness; S J Howell; G A Davies-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Small-intestine involvement in Waldenstrom's macroglobulinemia. Case report and review of the literature.

Authors:  L J Brandt; A Davidoff; L H Bernstein; L Biempica; B Rindfleisch; M L Goldstein
Journal:  Dig Dis Sci       Date:  1981-02       Impact factor: 3.199

3.  The relation of clinical and laboratory findings to the survival of patients with macroglobulinaemia.

Authors:  P Carter; J J Koval; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

4.  Intestinal malabsorption in macroglobulinemia.

Authors:  S Beker; P J Grases; F Merino; T Arends; J Guevara
Journal:  Am J Dig Dis       Date:  1971-07

5.  Waldenström's macroglobulinemia. Report of an autopsy case presenting with a pulmonary manifestation.

Authors:  M Tsuji; Y Yoshii; T Taka; K Min; H Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Monoclonal gammopathy (Waldenström's macroglobulinaemia) producing specific red cell antibody.

Authors:  O A Oluboyede; O Bademosi; A David-West; C O Thomas; T I Francis; L Luzzatto
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

7.  Waldenström's macroglobulinemia: review of 45 cases.

Authors:  M Krajny; W Pruzanski
Journal:  Can Med Assoc J       Date:  1976-05-22       Impact factor: 8.262

8.  Anomalous urinary proteins in patients with serum M-components.

Authors:  W Pruzanski; M A Ogryzlo
Journal:  Can Med Assoc J       Date:  1971-04-03       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.